MedTrace Logo

PPV: Pneumococcal Polysaccharide Vaccine in Older Adults

NCT00239694 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-08-04

No results posted yet for this study

Summary

The purpose of this study is to measure how long the improvement in the immune system lasts in older people after they have been vaccinated, and to examine the immune response in older people who get vaccinated a second time.

Conditions

  • Aging

Interventions

BIOLOGICAL

Pneumococcal Vaccine

One time preventative vaccine

BIOLOGICAL

Meningococcal Vaccine

One time preventative vaccine

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Dan L. Longo, MD · Scientific Director, National Insitute on Aging

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239694 on ClinicalTrials.gov